Hengdong Bio
Zhangshan
About Hengdong Bio
Hengdong Bio is dedicated to developing agonist antibody drugs with the potential to become new drugs, utilizing its advanced and unique core technology platform for screening, optimizing, and evaluating agonist antibodies.
Company Facts
- Operating status: Active
- IPO status: Private
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2025)
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/hengdong-bio-2695303 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.